Displaying 51 - 56 of 56 results
Released Company Title Industry Topic
08 Jan 2024
07:00 CET
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V. to Host Investor Meetings in January 2024 20103010 Biotechnology Meetings / events
06 Dec 2023
07:00 CET
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V. Reports Third Quarter 2023 Financial Results and Highlights Operational Progress 20103010 Biotechnology Corporate life
28 Nov 2023
07:00 CET
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V. to Report Q3 2023 Financial Results and Operational Progress on December 6, 2023 20103010 Biotechnology Other subject
07 Nov 2023
07:00 CET
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conference 20103010 Biotechnology Meetings / events
26 Oct 2023
07:00 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V. Provides Comprehensive Progress Report for Ongoing Varoglutamstat Clinical Program Following R&D Event and VIVA-MIND DSMB Dose Decision 20103010 Biotechnology Other subject
23 Oct 2023
07:00 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V. Reports Positive Outcome from Independent Data Safety Monitoring Board with Unanimous Decision for VIVA-MIND U.S. Study of Varoglutamstat in Alzheimer’s Disease to Proceed at Highest Investigated Dose 20103010 Biotechnology Other subject